A bold new era of precision medicine

Today’s I&I treatments are hitting an efficacy ceiling. Mirador is here to break through it with a precision-first approach that starts with the science. 
We pinpoint the right targets, the right patients and the fastest path forward. Our aspiration is to discover and develop first-in-class and best-in-class precision medicines that bring new hope and improve lives.

See our vision

The future of I&I: Powered by Mirador360™

Breakthroughs in I&I don’t happen by chance, they happen by design. Mirador360™ is our end-to-end precision discovery and development engine. Mirador360™ harnesses cutting-edge biology, multi-modal data, AI and advanced analytics to identify novel targets, select optimal combination therapies and pinpoint patients most likely to benefit from treatment. With it, we are accelerating a pipeline of potentially transformational therapies for immuno-fibrotic diseases.

Explore our science

Built by pioneers.
Focused on patients.

Our leadership team unites proven expertise in precision medicine, I&I and company building that drives transformational therapies for immune-mediated diseases. At Mirador, that experience fuels a bold but focused mission: to push beyond today’s limits in immuno-fibrotic diseases with science, clarity and urgency. We believe the strength of our team and the power of our science will deliver better lives for the patients we serve.

Meet our leaders

Join us at the vantage point

In Spanish, Mirador means “vantage point” or “lookout.” Join a team of dynamic leaders with diverse experiences and perspectives, united to define precision medicine for I&I.

Explore careers